MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Limula
Limula

Cell and gene therapies (CGT) represent a revolution in medicine, and give hope to many cancer patients with no alternatives. However, producing these treatments is currently so complex and expensive that many will not benefit from them. Our vision is to make CGT manufacturing simple, safe and reproducible with a self-contained automated bioreactor. Our patented platform technology allows clinicians to control their own supply, providing affordable personalised treatments on demand.
Our automated manufacturing platform enables the production of personalised cell therapy at scale, directly at the patient bedside.

Connect with Limula

2020

2020 Gold Switzerland

Sub industry

Medical Devices

Additional Industries
Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.